Related Experiment Video
Updated: Mar 23, 2026
19:53
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
106.6K
Bell's palsy syndrome: mimics and chameleons
Geraint Fuller1, Cathy Morgan1
1Department of Neurology, Gloucester Royal Hospital, Gloucester, UK.
Practical Neurology
|April 2, 2016
Summary
Bell's palsy is often diagnosed clinically, not by exclusion. Using the term "Bell's palsy syndrome" can improve clinical reasoning for facial weakness, with treatments like corticosteroids and antivirals aiding recovery.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Bell's palsy is a common condition causing facial weakness.
- Current diagnostic approaches are often described as a diagnosis of exclusion.
Purpose of the Study:
- To explore conditions that mimic Bell's palsy.
- To advocate for the use of the term "Bell's palsy syndrome" to enhance clinical reasoning.
Main Methods:
- Clinical review of Bell's palsy and its differential diagnoses.
- Analysis of diagnostic criteria and clinical reasoning pathways.
Main Results:
- Bell's palsy is characterized by a specific clinical syndrome, not solely by the exclusion of other causes.
- Mimics and chameleons of Bell's palsy can complicate diagnosis.
Conclusions:
- Adopting the term "Bell's palsy syndrome" may refine diagnostic processes.
- Corticosteroids improve outcomes, and antivirals may reduce long-term complications.
Keywords:
CLINICAL NEUROLOGY
Related Concept Videos
01:13Nonconscious Mimicry
5.2K
Nonconscious mimicry occurs when individuals alter their mannerisms to match the behaviors and expressions of those nearby, without intention.
5.2K
01:14Muscles for Facial Expressions
5.5K
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
5.5K
01:20Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
01:24Prosopagnosia
1.1K
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
1.1K
01:15Myasthenia Gravis: Diagnostic Tests
3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
01:26Chemical Synapses
12.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K